Foundation

THAROS™ was born out of collaboration between Dr Rosemary Waring (Honorary Reader of Toxicology, Birmingham University) and Professor John Hunter (Consultant Emeritus in Gastroenterology, Addenbrooke’s Hospital) in the area of gut health, malfermentation and the microbiome.

Timeline

2009

Professor John Hunter publishes a comparison of the human and horse gut. This leads to the identification of low pancreatic enzyme activity and too-rapid digestion as possible explanations for horse digestion problems.​

2010/11

Prof Hunter and Dr Rosemary Waring identify enzyme rich malt extract (ERME) as a source of enzymes to compensate for lack of adequate pancreatic enzyme activity in horses.

2012

ERME is tested in horses at a flat racing yard ranked in the top 5 in the UK. The horses show significantly improved condition and run better. Careful stool analysis shows a drop in acetate, which means nutrients are being better absorbed in the gut.

2016 to 2018

EquiNectar® is developed and the scientific programme is consolidated. The clinical and product development programme is optimised to focus on laminitis and wider animal health.

2018 onwards

EquiNectar® is sold to leading horse racing trainers around the world

2020

AviNectar, using our same patented Enzyme Rich Malt Extract is formulated for the racing pigeon market. Tests with British fanciers show encouraging results in terms of recovery from racing, improved condition and improved wellbeing.

2021

AviNectar is launched as a commercial product.